EADV 2023 Insights
Playback speed
10 seconds
EADV 2023 Insights: Understanding the Differences Between MOA and Target of Deucravacitinib Versus Other Approved JAKis
By
EADV 2023 Insights
FEATURING
Leon Kircik
By
EADV 2023 Insights
FEATURING
Leon Kircik
294 views
October 9, 2023
Comments 1
Login to view comments.
Click here to Login